rs139344924

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003664.5(AP3B1):​c.2661C>A​(p.Phe887Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0102 in 1,614,086 control chromosomes in the GnomAD database, including 110 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0069 ( 5 hom., cov: 32)
Exomes 𝑓: 0.011 ( 105 hom. )

Consequence

AP3B1
NM_003664.5 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 2.63

Publications

12 publications found
Variant links:
Genes affected
AP3B1 (HGNC:566): (adaptor related protein complex 3 subunit beta 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is part of the heterotetrameric AP-3 protein complex which interacts with the scaffolding protein clathrin. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2012]
AP3B1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0114659965).
BP6
Variant 5-78039191-G-T is Benign according to our data. Variant chr5-78039191-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 210189.We mark this variant Benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00694 (1056/152260) while in subpopulation SAS AF = 0.0137 (66/4828). AF 95% confidence interval is 0.0111. There are 5 homozygotes in GnomAd4. There are 482 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP3B1NM_003664.5 linkc.2661C>A p.Phe887Leu missense_variant Exon 23 of 27 ENST00000255194.11 NP_003655.3 O00203-1A0A0S2Z5J4
AP3B1NM_001271769.2 linkc.2514C>A p.Phe838Leu missense_variant Exon 23 of 27 NP_001258698.1 O00203-3A0A0S2Z5J4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP3B1ENST00000255194.11 linkc.2661C>A p.Phe887Leu missense_variant Exon 23 of 27 1 NM_003664.5 ENSP00000255194.7 O00203-1

Frequencies

GnomAD3 genomes
AF:
0.00694
AC:
1056
AN:
152142
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00195
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00412
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0137
Gnomad FIN
AF:
0.00264
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0117
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00774
AC:
1947
AN:
251458
AF XY:
0.00819
show subpopulations
Gnomad AFR exome
AF:
0.00142
Gnomad AMR exome
AF:
0.00338
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00259
Gnomad NFE exome
AF:
0.0113
Gnomad OTH exome
AF:
0.00912
GnomAD4 exome
AF:
0.0105
AC:
15376
AN:
1461826
Hom.:
105
Cov.:
32
AF XY:
0.0105
AC XY:
7618
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.00146
AC:
49
AN:
33480
American (AMR)
AF:
0.00369
AC:
165
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00126
AC:
33
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39686
South Asian (SAS)
AF:
0.0128
AC:
1100
AN:
86258
European-Finnish (FIN)
AF:
0.00307
AC:
164
AN:
53416
Middle Eastern (MID)
AF:
0.00919
AC:
53
AN:
5768
European-Non Finnish (NFE)
AF:
0.0117
AC:
13054
AN:
1111972
Other (OTH)
AF:
0.0125
AC:
757
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
820
1641
2461
3282
4102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
482
964
1446
1928
2410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00694
AC:
1056
AN:
152260
Hom.:
5
Cov.:
32
AF XY:
0.00647
AC XY:
482
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.00195
AC:
81
AN:
41570
American (AMR)
AF:
0.00412
AC:
63
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.0137
AC:
66
AN:
4828
European-Finnish (FIN)
AF:
0.00264
AC:
28
AN:
10596
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0117
AC:
798
AN:
68002
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
58
116
174
232
290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00945
Hom.:
19
Bravo
AF:
0.00636
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.0114
AC:
44
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.0115
AC:
99
ExAC
AF:
0.00784
AC:
952
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.0109
EpiControl
AF:
0.00865

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 28, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Phe887Leu in exon 23 of AP3B1: This variant is not expected to have clinical sig nificance because it has been identified in 1.2% (99/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs139344924). -

Hermansky-Pudlak syndrome 2 Benign:2
Mar 20, 2019
Johns Hopkins Genomics, Johns Hopkins University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AP3B1: BP4, BS1, BS2 -

Hermansky-Pudlak syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Feb 05, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.23
T;.
Eigen
Benign
-0.17
Eigen_PC
Benign
0.063
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.72
T;T
MetaRNN
Benign
0.011
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L;.
PhyloP100
2.6
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.040
N;N
REVEL
Benign
0.059
Sift
Benign
0.65
T;T
Sift4G
Benign
0.65
T;T
Polyphen
0.0010
B;.
Vest4
0.35
MutPred
0.37
Gain of sheet (P = 0.0827);.;
MVP
0.28
MPC
0.068
ClinPred
0.013
T
GERP RS
5.8
PromoterAI
-0.036
Neutral
Varity_R
0.10
gMVP
0.58
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139344924; hg19: chr5-77335015; COSMIC: COSV106092631; COSMIC: COSV106092631; API